市場調査レポート

商品コード

1651702

ナノメディシンの市場規模、シェア、成長分析：製品タイプ別、用途別、適応症別、モダリティ別、地域別 - 産業予測 2025～2032年

Nanomedicine Market Size, Share, and Growth Analysis, By Product Type (Nano Molecules, Nanoparticles), By Application (Vaccines, Regenerative Medicines), By Indication, By Modality, By Region - Industry Forecast 2025-2032

出版日: 2025年02月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 786,149円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 919,646円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,053,143円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.33円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ナノメディシン市場規模は2023年に1,994億米ドルとなり、予測期間（2025-2032年）のCAGRは12.4%で、2024年の2,241億3,000万米ドルから2032年には5,709億8,000万米ドルに成長する見通しです。

ナノメディシン市場は、満たされていない医療ニーズに対応し、患者の転帰を向上させる革新的なソリューションの開発に注力していることから、大きな成長が見込まれています。薬物送達の改善、バイオアベイラビリティ、標的治療などの利点を持つナノメディシンは、高度なナノテクノロジーを活用して、より正確で個別化された治療を実現します。促進要因としては、新規医療用途を可能にするナノテクノロジーの進歩が挙げられるが、一方で高い開発コストや生産規模の拡大の複雑さといった課題を克服する必要があります。こうしたハードルにもかかわらず、この市場には、特に慢性疾患の蔓延が高まる中、標的薬物送達システムと診断において、十分なビジネスチャンスがあります。全体として、米国のナノメディシン市場は持続的な成長を遂げ、革新的なソリューションを通じてヘルスケア提供に変革をもたらすと期待されています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Imina Technologies SA（Switzerland）
NANONICS IMAGING Ltd.（U.S.）
Altair Nanotechnologies Inc.（U.S.）
Bruker Corporation（U.S.）
Kleindiek Nanotechnik GmbH（Germany）
eSpin Technologies, Inc.（U.S.）
Advanced Nano Products Co., Ltd.（South Korea）
Applied Nanotech, Inc.（U.S.）
Biosensors International Group, Ltd.（Singapore）
Thermo Fisher Scientific Inc.（U.S.）
BASF（Germany）
Nanotech Energy（U.S.）
Advanced Test Equipment Corporation（U.S.）
Werfen（Spain）
SomaLogic（U.S.）
Palamedrix（U.S.）
NaNotics LLC（U.S.）
Innovasis, Inc.（U.S.）
Promimic（U.S.）

結論と提言

Product Code: SQMIG35I2200

Nanomedicine Market size was valued at USD 199.4 billion in 2023 and is poised to grow from USD 224.13 billion in 2024 to USD 570.98 billion by 2032, growing at a CAGR of 12.4% during the forecast period (2025-2032).

The nanomedicine market is poised for significant growth as it focuses on developing innovative solutions that address unmet medical needs and enhance patient outcomes. With advantages such as improved drug delivery, bioavailability, and targeted therapies, nanomedicine leverages advanced nanotechnology to create more precise and personalized treatments. Driving factors include advancements in nanotechnology, which enable novel medical applications, while challenges like high development costs and the complexity of scaling up production must be navigated. Despite these hurdles, the market offers ample opportunities, especially in targeted drug delivery systems and diagnostics amidst the rising prevalence of chronic diseases. Overall, the US nanomedicine market is expected to experience sustainable growth, transforming healthcare delivery through innovative solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nanomedicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nanomedicine Market Segments Analysis

Global Nanomedicine Market is segmented by Product Type, Application, Indication, Modality and region. Based on Product Type, the market is segmented into Nano Molecules, Nanoparticles, Liposomes, Polymer and Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes and Nanodevices. Based on Application, the market is segmented into Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging,in-vitro diagnostics, Therapeutics and Others. Based on Indication, the market is segmented into Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases and Others. Based on Modality, the market is segmented into Treatment and Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nanomedicine Market

The increasing prevalence of chronic illnesses like cancer, cardiovascular diseases, and diabetes significantly propels the growth of the nanomedicine market. This innovative field provides targeted and personalized treatment solutions that not only enhance therapeutic effectiveness but also contribute to better overall patient well-being. By leveraging nanotechnology, healthcare professionals can design treatments that specifically address individual patient needs, leading to more precise interventions. As the demand for advanced medical solutions continues to rise, the role of nanomedicine in improving health outcomes becomes increasingly vital, positioning it as a crucial market driver in the evolving landscape of modern medicine.

Restraints in the Nanomedicine Market

The nanomedicine market faces notable challenges due to the substantial research and development expenses associated with creating and commercializing these products. The intricate manufacturing processes combined with stringent regulatory requirements result in elevated costs that can impede the broader acceptance and adoption of nanomedicine solutions. Consequently, these financial barriers may deter potential investors and limit the number of products that successfully transition from the research phase to market availability, ultimately slowing down advancements in the field and restricting the potential benefits that nanomedicine could bring to healthcare.

Market Trends of the Nanomedicine Market

The nanomedicine market is experiencing significant growth, propelled by the shift towards personalized medicine. By harnessing nanotechnology, healthcare providers can develop targeted therapies that cater to individual patient profiles, optimizing efficacy and minimizing side effects. This trend is becoming increasingly prevalent as advancements in nanotechnology enable precise drug delivery systems, improved diagnostics, and tailored therapies based on genetic and molecular biomarkers. As healthcare systems focus on patient-centric care, the integration of personalized approaches through nanomedicine is set to drive market expansion, fostering innovations and the development of therapeutics that are customized to enhance treatment outcomes in diverse medical conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Nanomedicine Market Size by Product Type & CAGR (2025-2032)

Market Overview
Nano Molecules
Nanoparticles
Liposomes
Polymer and Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Nanoshells
Nanotubes
Nanodevices

Global Nanomedicine Market Size by Application & CAGR (2025-2032)

Market Overview
Vaccines
Regenerative Medicines
Diagnostic Imaging
Drug Delivery
Implants
In-Vitro Imaging
In-Vitro Diagnostics
Therapeutics
Others

Global Nanomedicine Market Size by Indication & CAGR (2025-2032)

Market Overview
Oncological Diseases
Infectious Diseases
Cardiovascular Diseases
Orthopedic Disorders
Neurological Disorders
Urological Disorders
Ophthalmological Diseases
Immunological Diseases
Anti-Inflammatory Diseases
Anti-Infective Diseases
Others

Global Nanomedicine Market Size by Modality & CAGR (2025-2032)

Market Overview
Treatment
Diagnostics

Global Nanomedicine Market Size & CAGR (2025-2032)

North America (Product Type, Application, Indication, Modality)
- US
- Canada
Europe (Product Type, Application, Indication, Modality)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Indication, Modality)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Indication, Modality)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Indication, Modality)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Imina Technologies SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NANONICS IMAGING Ltd. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altair Nanotechnologies Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kleindiek Nanotechnik GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
eSpin Technologies, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Nano Products Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Nanotech, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanotech Energy (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Test Equipment Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomaLogic (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Palamedrix (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NaNotics LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovasis, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promimic (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ナノメディシンの市場規模、シェア、成長分析：製品タイプ別、用途別、適応症別、モダリティ別、地域別 - 産業予測 2025～2032年

Nanomedicine Market Size, Share, and Growth Analysis, By Product Type (Nano Molecules, Nanoparticles), By Application (Vaccines, Regenerative Medicines), By Indication, By Modality, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ナノメディシン市場規模：製品タイプ別& CAGR（2025-2032）

ナノメディシン市場規模：用途別& CAGR（2025-2032）

ナノメディシン市場規模：適応症別& CAGR（2025-2032）

ナノメディシン市場規模：モダリティ別& CAGR（2025-2032）

ナノメディシン市場規模：地域別& CAGR（2025-2032）